 |
UCLA
Study Highlights Long-Term Risks of Angeogenesis Inhibitors
This study -- Published in
the Aug. 24 journal -- Cell -- examined the effect of blocking VEGF signaling
from within endothelial cells, a mechanism used by some small-molecule
drugs currently being tested in late-phase clinical trials. The result
was unexpected and sobering. More than half of the mice in the study
suffered heart attacks and fatal strokes, while those that remained
alive developed serious systemic vascular illness, said Luisa
Iruela-Arispe (photo right), a professor of molecular, cell and developmental
biology and director of the Cancer Cell Biology program at UCLA's
Jonsson Cancer Center.
UCI
Researchers Contend Brain Cells Work Differently Than Previously Thought
Raju Metherate's (photo right) study published in Nature
Neuroscience shows for the first time that axons -- hairlike extensions linking neurons --
do not just transmit information, they can turn the signal up or down
with the right stimulation. This finding may open the door to developing treatments for psychiatric disorders such as depression and
schizophrenia in which it is thought that different parts of the brain do not communicate correctly with each other.
- USC
Study Links Genes to Increased Asthma Risk
The study will appear in the journal Thorax,
which is now available online, found that children who carried variations in two genes and lived within 75 meters of a major road were up to nine times more likely to develop asthma than children who
lived further away.
|
|
- Advanced Medical Optics (Santa Ana):
-
Allergan (Irvine):
- Amgen (Thousand Oaks):
- Cobalis (Irvine):
- Cortex Pharmaceuticals (Irvine):
- IDM Pharma (Irvine):
-
Innovamed (Irvine)
- Kythera Biopharmaceuticals (Agoura
Hills):
- Masimo (Irvine)
-
Molecular Express (Rancho Dominguez):
- Obagi Medical Products (Long Beach):
- St Jude Cardiac Management Division
(Sylmar):
|
|
|
Osmetech
Molecular Diagnostics
(Pasadena, CA)
Sr
Production Planner
See
list of open positions at:
http://www.socalbio.org/career_center/jobs.htm
|
|
|
|
 |
|
Join
the Southern California Biomedical
Council and Enjoy the Benefits of our
Group Purchasing Program
The SoCalBio Group
Purchasing Program includes the following
providers:
Program discounts and other benefits are offered
exclusively to SoCalBio device, biotech, and R&D
member companies and service providers in Los
Angeles, Orange, Ventura, Santa Barbara, San
Bernardino and Riverside counties.
See
SoCalBio
membership information and benefits at: http://www.socalbio.org/membership/membership_form.htm
|
|
 |
|
Coming
This Thursday

SoCalBio
52nd Networking Forum
August 30, 2007,
5 - 9 pm
USC
Davidson Conference Center
3415 S Figueroa St, LA, CA 90007
RSVP
Now: https://www.123signup.com/register?id=qrsfy
Are We
Closer to Developing
a True Cancer Vaccine?
Cancer
vaccines hold great promise for providing therapies
that are non-toxic, less-invasive, and
longer-lasting than current treatments. But delivering on this
promise has posed one of the greatest challenges
facing the life sciences. This challenge has been embraced
by the biotechnology industry including local companies such as ImmunoCellular
Therapeutics, a company seeking to develop vaccines against malignancies including
brain tumors. Company founder and chairman Dr. John Yu,
co-director of the Comprehensive Brain Tumor Program at
Cedars-Sinai Medical Center, will provide an
overview of the commercial state of cancer vaccine
development and his company's approach in tackling the
challenges of such vaccine design. A panel
discussion will follow to address
whether we are closer to developing a cancer vaccine.
Presentation
by

John Yu,
M.D., Chairman
ImmunoCellular Therapeutics
(Los Angeles)
Panel
Discussion Participants:
Adrian Bot, M.D., Ph.D., Sr. Director, Translational
Medicine, MannKind
Corp. (Valencia)
Aya Jakobovits, Ph.D., CSO, Agensys
(Santa Monica)
Jay Sharma, Pres. & CEO, Celprogen
(San Pedro)
Coming Soon
SoCalBio
Breakfast in OC
Register
Now
October 10, 2007
7:00 - 9:30 am
UCI University Club in Irvine
Going
Public Via Reverse Mergers
Where Is the Value Proposition
|
The SoCalBio
Networking Forum and Breakfast in OC series bring together leaders from all
segments of the life-science industry to share
insights and learn about:
-
Innovation
best practices
-
Device
and biotech business trends
-
Technology
convergence opportunities, and
-
Broad-reaching
public policies shaping the commercialization of
innovations and healthcare service delivery in the
U.S. and abroad.
Click
here for examples of past forums |
Thanks
to Forum and Breakfast Sponsors
Sponsorship and Display
Opportunities Available
Contact SoCalBio at scbc@socalbio.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SoCalBio/LINC
Fall Golf Classic
September 24, 2007
Marbella Country Club,
San Juan Capistrano
Click
for more information
Thanks
to SoCalBio/LINC
Golf Tournament Sposnors
Interested
in sponsoring the golf tournament?
Contact Colby
Poppleton at (714) 557-5100 ext 16
or Colby@rodheim-marketing.com
|
 |
February 28 -
29, 2008
2nd
SoCalBio Human Resources
Conference & Job Fair
(Los Angeles).... Read
more
April 10, 2008 (with a
pre-conference CEO/Investor
networking dinner on April 9)
10th
SoCalBio Investor
Conference .....
Read more |
 |
September 19, 2007
Biotech
Vendor Services, Inc.
Orange County Biomedical Day:
Bringing the Medical Device and Biotech Communities Together for
a Common Goal (Irvine)... Read
more
September 26 -
29, 2007
Biomedical
Engineering Society
BMES 2007: Engineering the Future of Biology and
Medicine (Hollywood)... Read
more
October 30, 2007
DeviceSpace
Medical Device and Diagnostics Career
Fair (Irvine) ... Read more
November 7- 8, 2007
SBS Symposium on Stem Cell Research
Back to
Pharmacology: Stem Cells & Primary Cells in Drug Discovery (Anaheim)
... Read more |
|